WCG Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.53M Sell
30,812
-3,577
-10% -$833K 0.21% 113
2025
Q4
$7.12M Buy
34,389
+22,434
+188% +$4.44M 0.2% 117
2025
Q3
$2.22M Sell
11,955
-1,010
-8% -$173K 0.14% 144
2025
Q2
$1.98M Buy
+12,965
New +$1.99M 0.13% 162
2024
Q3
Sell
-12,124
Closed -$1.77M 312
2024
Q2
$1.77M Buy
12,124
+1,395
+13% +$207K 0.13% 146
2024
Q1
$1.7M Sell
10,729
-5,111
-32% -$814K 0.14% 135
2023
Q4
$2.48M Sell
15,840
-2,902
-15% -$445K 0.18% 114
2023
Q3
$3.02M Buy
+18,742
New +$3.09M 0.22% 99
2022
Q4
Sell
-4,953
Closed -$940K 222
2022
Q3
$940K Buy
4,953
+683
+16% +$116K 0.12% 133
2022
Q2
$758K Buy
+4,270
New +$761K 0.11% 141

Other funds holding JNJ

WCG Wealth Advisors's JNJ Position: Q1 2026 in Review

WCG Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 10% in Q1 2026, selling an estimated $833K and leaving 30,812 shares worth $7.53M. The position accounts for 0.21% of the portfolio, ranked #113.

WCG Wealth Advisors first reported a position in JNJ in Q2 2022 and has held it in 10 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • WCG Wealth Advisors held 30,812 shares of Johnson & Johnson worth $7.53M as of Q1 2026.
  • WCG Wealth Advisors sold 3,577 Johnson & Johnson shares in Q1 2026, an estimated $833K.
  • Johnson & Johnson made up 0.21% of WCG Wealth Advisors's portfolio in Q1 2026, its #113 holding.
  • WCG Wealth Advisors first reported a position in Johnson & Johnson in Q2 2022 and has held it in 10 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on WCG Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.